← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2013Last known activity
Dec 7, 2018
Acquired by IQVIA on Sep 17, 2013
Timeline
1990s
- Jan 1, 1998
Novella Clinical— Founded
2010s
- Jun 1, 2010
Prologue Research International— Acquired
- Sep 17, 2013
IQVIA— Acquired By
Drugs by trial phase (30 distinct, 30 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 8 via acquisition)
Phase 2 (5 own, 3 via acquisition)
Phase 1 (11 own, 1 via acquisition)
Indications
Studied for
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Glioblastoma
- Herpes Labialis
- Lung Neoplasms
- Mucositis
- Neoplasms
- Ovarian Neoplasms
- Psoriasis
- Rhinitis
- Rhinitis, Allergic
- Small Cell Lung Carcinoma
- Stomatitis
- Wounds and Injuries
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (16)
- NCT03775434CollaboratorPhase 1/Phase 2Dec 7, 2018
- NCT03692429CollaboratorPhase 1Oct 1, 2018
- NCT03466320CollaboratorPhase 1Sep 30, 2018
- NCT03639883Study directorPhase 1/Phase 2Sep 30, 2018
- NCT03438318CollaboratorPhase 1Mar 15, 2018
- NCT03474640CollaboratorPhase 1Mar 14, 2018
- NCT03319628CollaboratorPhase 1Dec 12, 2017
- NCT03431610CollaboratorPhase 1Nov 13, 2017
- NCT03445013CollaboratorPhase 1Oct 13, 2017
- NCT03077477CollaboratorPhase 1Apr 15, 2017
- NCT02871492CollaboratorPhase 2Nov 29, 2016
- NCT02546102CollaboratorPhase 3Dec 1, 2015
- NCT02508389CollaboratorPhase 2Oct 1, 2015
- NCT02539719Study directorPhase 1Aug 1, 2015
- NCT02500914Study directorPhase 1Jun 1, 2015
Details
- Founded
- Morrisville, NC, US Jan 1, 1998
- Last known activity
- Dec 7, 2018